3084. [Kinetics of proliferation in human tumor cells].3085. [Administration of anticancer agent into the bronchial artery in lung cancer--its significance in combination with other therapy].3086. [Dosage schedule of new anticancer drugs--evaluation of the use of 3 anticancer drugs in the study of phases 1 and 2].3087. [Side effects of bleomycin observed through x-ray figures].3088. [Fatal case of cervical cancer treated by anti-neoplastic agents, Bleomycin].3089. [Pre-surgical continuous arterial infusion of antineoplastic agents in osteosarcoma].3090. [Pharmacodynamics of antineoplastic agents in vivo].3091. [Structural anomaly of HeLa cell chromosomes caused by Bleomycin].3092. [Sensitivity test of Antineoplastic agent sensitivity test in the terminal stage of lung cancer].3093. [Indication for antineoplastic agents (using 3H-thymidine)].3094. [Antineoplastic agent sensitivity test using a diffusion chamber].3095. [Evaluation of screening tests using methylcholanthrene-sarcoma].3096. [Evaluation of antineoplastic agents by INK and MNG methods].3097. [Effect of Bleomycin on the chromosome of HeLa cells].3098. [Potentiation of the effects of antineoplastic agents].3099. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents].3100. [Cancer chemotherapy and blood coagulation-fibrinolysis system]. |